Measuring and Statistically Testing the Size of the Effect of a Chemical Compound on a Continuous In-Vitro Pharmacological Response Through a New Statistical Model of Response Detection Limit.
Diaz, Francisco J; McDonald, Peter R; Pinter, Abraham; Chaguturu, Rathnam.
J Biopharm Stat
; 25(4): 757-80, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-24905187
Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatment.
Model-free tests of equality in binary data under an incomplete block design.
Statistical Significance Versus Clinical Importance of Observed Effect Sizes: What Do P Values and Confidence Intervals Really Represent?
A simple and flexible graphical approach for adaptive group-sequential clinical trials.
Adaptive graph-based multiple testing procedures.
Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.
Prevention of mother-to-child transmission of HIV: assessing the accuracy of routinely collected data on maternal antiretroviral prophylaxis coverage in Kenya.
BOIN-ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes.
The effect of Fisher information matrix approximation methods in population optimal design calculations.
Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts.